Literature DB >> 10983865

Characterization of beta-adrenoceptors responsible for venom production in the venom gland of the snake Bothrops jararaca.

N Yamanouye1, S M Carneiro, C N Scrivano, R P Markus.   

Abstract

We have shown that the stimulation of beta-adrenoceptors is an important step in venom production in the Bothrops jararaca venom gland. In the present study, the pharmacological profile of the beta-adrenoceptor present in Bothrops jararaca venom gland was characterized by radioligand binding assay and by the ability of isoprenaline to promote accumulation of cyclic AMP in dispersed secretory cells. In both cases, the venom glands were obtained from non-extracted snakes (quiescent stage) or from snakes which venom was extracted 4 days before sacrifice (venom production stimulated stage). [125I]-iodocyanopindolol ([125I]-ICYP) bound to extracted gland membranes in a concentration-dependent and saturable manner, but with low affinity. Propranolol, beta1- or beta2-selective adrenoceptors ligands displaced the [125I]-ICYP binding with low affinity, while selective beta3-adrenoceptor ligands did not displace the [125I]-ICYP binding. The displacement of [125I]-ICYP by propranolol was similar in non-extracted and extracted glands, showing the presence of beta-adrenoceptors in both stages. In dispersed secretory cells of non-extracted glands, isoprenaline (1 microM) increased the cyclic AMP production and propranolol (10 microM) was able to block this effect. On the other hand, in extracted glands, isoprenaline had no effect. The results suggest that the beta-adrenoceptors present in the Bothrops jararaca venom glands are different from those (beta1, beta2 or beta3) described in mammals, but are coupled to the Gs protein, like the known beta-adrenoceptor subtypes. Moreover, previous in vivo stimulation of venom production desensitizes the beta-adrenoceptors system and, although the receptors could be detected by binding studies, they are not coupled to the Gs protein, indicating that beta-adrenoceptors stimulation contributes to the initial steps of venom synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983865     DOI: 10.1016/s0024-3205(00)00626-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Snake venom gene expression is coordinated by novel regulatory architecture and the integration of multiple co-opted vertebrate pathways.

Authors:  Blair W Perry; Siddharth S Gopalan; Giulia I M Pasquesi; Drew R Schield; Aundrea K Westfall; Cara F Smith; Ivan Koludarov; Paul T Chippindale; Mark W Pellegrino; Edward B Chuong; Stephen P Mackessy; Todd A Castoe
Journal:  Genome Res       Date:  2022-06-01       Impact factor: 9.438

2.  A transcriptomic analysis of gene expression in the venom gland of the snake Bothrops alternatus (urutu).

Authors:  Kiara C Cardoso; Márcio J Da Silva; Gustavo G L Costa; Tatiana T Torres; Luiz Eduardo V Del Bem; Ramon O Vidal; Marcelo Menossi; Stephen Hyslop
Journal:  BMC Genomics       Date:  2010-10-26       Impact factor: 3.969

3.  Venom-related transcripts from Bothrops jararaca tissues provide novel molecular insights into the production and evolution of snake venom.

Authors:  Inácio L M Junqueira-de-Azevedo; Carolina Mancini Val Bastos; Paulo Lee Ho; Milene Schmidt Luna; Norma Yamanouye; Nicholas R Casewell
Journal:  Mol Biol Evol       Date:  2014-12-09       Impact factor: 16.240

4.  The Primary Duct of Bothrops jararaca Glandular Apparatus Secretes Toxins.

Authors:  Richard Hemmi Valente; Fernanda Sakai; José Antonio Portes-Junior; Luciana Godoy Viana; Sylvia Mendes Carneiro; Jonas Perales; Norma Yamanouye
Journal:  Toxins (Basel)       Date:  2018-03-13       Impact factor: 4.546

5.  Physiological demands and signaling associated with snake venom production and storage illustrated by transcriptional analyses of venom glands.

Authors:  Blair W Perry; Drew R Schield; Aundrea K Westfall; Stephen P Mackessy; Todd A Castoe
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.